Healthcare DIVE August 5, 2024
Decreased access to diagnostic tests, worsening patient care and practice closures are among the concerns the AMA and others have raised as the regulation takes effect.
Many doctors and laboratories don’t have the resources to comply with the Food and Drug Administration’s final rule on the regulation of laboratory developed tests and will likely scale back the number of tests they perform, experts from the American Medical Association and other healthcare groups warned at a meeting last week.
Clinical labs are now assessing the staffing and financial burdens they face as a result of the rule, Octavia Peck Palmer, president of the Association for Diagnostics & Laboratory Medicine, said during a July 30 panel discussion at the group’s annual meeting....
Today's Sponsors
Today's Sponsor